Central Adelaide Local Health Network (CALHN) appreciates the support of our clinical researchers in ensuring the safety and care of our patients and staff during these challenging times. As developments surrounding the COVID-19 pandemic evolve, investigators and coordinators are asked to familiarise themselves with the current arrangements for new and existing research projects and clinical trials.
COVID-19 Vaccination Requirements for Contractors
Contractors who perform work at a CALHN site are required to be vaccinated against COVID-19.
This direction applies to all persons, including external consultants and contractors (including monitors and auditors), who attend a healthcare setting during their work or duties. It also includes those whose attendance is incidental (such as couriers, delivery drivers or suppliers). Such persons will be requested to provide evidence of vaccination status by clinical trial staff.
COVID-19 Research Submissions
Ethics and governance review of projects concerning COVID-19 will be expedited as required. Researchers wishing to conduct clinical studies regarding COVID-19 must consult with the CALHN Infectious Diseases department and/or the SA Pathology Microbiology and Infectious Diseases unit (whichever is applicable) to ensure the unit has sufficient capacity/capability to support the study.
Email: Health.CALHNResearchGovernance@sa.gov.au
Research Amendments in Response to COVID-19
Any queries and changes to current research projects should be communicated to CALHN Research Services at the following contacts:
Budgets
Email:: Health.CALHNResearchFinance@sa.gov.au
Grant funded projects
Email: Health.CALHNResearchGrants@sa.gov.au
Research projects/clinical trials reviewed by CALHN HREC (e.g. protocol changes/deviations or study suspension)
Email: Health.CALHNResearchEthics@sa.gov.au
Research projects/clinical trials reviewed by external HREC (e.g. protocol changes/deviations or study suspension)
Email:: Health.CALHNResearchGovernance@sa.gov.au
National Advice on Clinical Trials
National advice on the management of clinical research has been posted. The guidance provides general information and advice to researchers involved in clinical research, institutions conducting or overseeing research, HRECs, and sponsors in the context of the COVID-19 pandemic.
This advice and future updates is posted on the Department of Health Clinical Trials Page.